Kaliumchloride + Glucose B. Braun

Potassium chloride and glucose, the active ingredients in Kaliumchloride + Glucose B. Braun, are an electrolyte and carbohydrate presented as an injection solution for intravenous use. They are employed to correct low blood potassium levels and to provide an energy source during hospital therapy. GNH USA supplies Kaliumchloride + Glucose B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kaliumchloride + Glucose B. Braun is used in clinical settings to manage electrolyte and metabolic needs. - Hypokalemia: restores normal potassium concentrations in patients with low serum potassium. - Potassium replacement: provides controlled potassium supplementation during intravenous therapy. - Parenteral nutrition: supplies potassium and glucose as part of total nutrient admixtures for patients unable to eat orally. - Prevention of hypoglycemia: delivers glucose to maintain blood sugar levels during fasting or critical illness.

Adverse reactions may occur with intravenous potassium‑glucose solutions.

Common Side Effects: - Local irritation at the infusion site. - Mild nausea or vomiting. - Transient hyperglycemia. - Mild headache. - Temporary increase in serum potassium that resolves with monitoring.

Serious or Rare Side Effects: - Severe hyperkalemia leading to cardiac arrhythmia. - Anaphylactic or severe allergic reaction. - Phlebitis or thrombophlebitis. - Metabolic acidosis. - Hyperosmolar hyperglycemic state in susceptible patients.

Use Kaliumchloride + Glucose B. Braun with careful clinical monitoring. - Cardiac monitoring: observe ECG for arrhythmias in patients at risk of hyperkalemia. - Renal function: assess kidney function before and during therapy to avoid potassium accumulation. - Blood glucose: monitor glucose levels, especially in diabetic patients. - Infusion rate: administer at recommended rates to prevent rapid shifts in potassium or glucose. - Compatibility: verify compatibility with other IV solutions before mixing. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potassium‑glucose injections can interact with several medicines.

Major Interactions (Avoid): - ACE inhibitors or ARBs: may potentiate hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): increase risk of elevated serum potassium. - Insulin: rapid glucose infusion can blunt insulin’s effect, requiring dose adjustment.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycemia. - Digoxin: high potassium levels can alter digoxin toxicity risk. - Sodium bicarbonate: concurrent use may affect serum electrolyte balance.